Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

BACKGROUND: Most patients with malignant peritoneal mesothelioma (MPM) present with late-stage, unresectable disease that responds poorly to systemic chemotherapy while, at the same time, effective targeted therapies are lacking. We assessed the efficacy of cytoreductive surgery (CRS) and hypertherm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Magge, Deepa, Zenati, Mazen S., Austin, Frances, Mavanur, Arun, Sathaiah, Magesh, Ramalingam, Lekshmi, Jones, Heather, Zureikat, Amer H., Holtzman, Matthew, Ahrendt, Steven, Pingpank, James, Zeh, Herbert J., Bartlett, David L., Choudry, Haroon A.
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100549/
https://ncbi.nlm.nih.gov/pubmed/24322529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3358-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares